Table 1. Protection From Tumor Growth... | American Society of Hematology

Table 1.

Protection From Tumor Growth After Immunization With Id/GM-CSF CpG ODN Is Limited to Tumors Expressing the Target Antigen

	Wild Type 38C13 Median Survival	Wild Type 38C13 % Survivors	Id Variant 38C13 Median Survival	Id Variant 38C13 % Survivors
No immunization	23 d	0%	23 d	0%
Id/GM-CSF	37 d	30%	23 d	0%
Id/GM-CSF with CpG ODN	^*	70%	25 d	0%

	Wild Type 38C13 Median Survival	Wild Type 38C13 % Survivors	Id Variant 38C13 Median Survival	Id Variant 38C13 % Survivors
No immunization	23 d	0%	23 d	0%
Id/GM-CSF	37 d	30%	23 d	0%
Id/GM-CSF with CpG ODN	^*	70%	25 d	0%

Median survival not reached.